SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-010123
Filing Date
2020-04-27
Accepted
2020-04-27 07:00:27
Documents
2
Period of Report
2020-04-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea121077-6k_kamadaltd.htm 6-K 12031
2 KAMADA AND KEDRION BIOPHARMA ANNOUNCE GLOBAL COLLABORATION FOR THE DEVELOPMENT, ea121077ex99-1_kamadaltd.htm EX-99.1 18335
  Complete submission text file 0001213900-20-010123.txt   31342
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 20817206
SIC: 2834 Pharmaceutical Preparations